OTHER IDH1-MUTATED POSITIVE HEMATOLOGIC MALIGNANCIES

Clinical trials for OTHER IDH1-MUTATED POSITIVE HEMATOLOGIC MALIGNANCIES explained in plain language.

Never miss a new study

Get alerted when new OTHER IDH1-MUTATED POSITIVE HEMATOLOGIC MALIGNANCIES trials appear

Sign up with your email to follow new studies for OTHER IDH1-MUTATED POSITIVE HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets rare mutation in blood cancers

Disease control Recruiting now

This early-stage trial tests an oral drug called AG-120 in people with advanced blood cancers, like leukemia, that have a specific IDH1 mutation. The study aims to find the safest dose and see if the drug can control the disease. About 291 participants will take the drug daily un…

Matched conditions: OTHER IDH1-MUTATED POSITIVE HEMATOLOGIC MALIGNANCIES

Phase: PHASE1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated Jun 23, 2026 20:32 UTC

OTHER IDH1-MUTATED POSITIVE HEMATOLOGIC MALIGNANCIES

Get alerted when new OTHER IDH1-MUTATED POSITIVE HEMATOLOGIC MALIGNANCIES trials appear

New pill targets rare mutation in blood cancers